Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas (Q34461120)

2 August 2017

title

Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas (English)

1 reference

2 August 2017

11

Jonathan Pollack

1 reference

2 August 2017

10

Blake Gilks

1 reference

2 August 2017

Lindsay A Brown

1

1 reference

2 August 2017

Julie Irving

2

1 reference

2 August 2017

Robin Parker

3

1 reference

2 August 2017

Hanna Kim

4

1 reference

2 August 2017

Joshua Z Press

5

1 reference

2 August 2017

Teri A Longacre

6

1 reference

2 August 2017

Stephen Chia

7

1 reference

2 August 2017

Anthony Magliocco

8

1 reference

2 August 2017

Nikita Makretsov

9

1 reference

2 August 2017

David Huntsman

12

1 reference

2 August 2017

language of work or name

English

0 references

publication date

19 October 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

100

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

264-270

1 reference

Chromosome 11q13 markers and D-type cyclins in breast cancer

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Cyclin D1, EMS1 and 11q13 amplification in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Overexpression of cyclin D1 in epithelial ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Amplification of the BRCA2 Pathway Gene EMSY in Sporadic Breast Cancer Is Related to Negative Outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Molecular portraits of human breast tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Cyclin D1 is a nuclear protein required for cell cycle progression in G1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Genetic instability as a consequence of inappropriate entry into and progression through S-phase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

11q13 amplification in local recurrence of human primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

BRCA‐related ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

EMSY, a BRCA-2 partner in crime

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

A novel BRCA2-binding protein and breast and ovarian tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Hallmarks of 'BRCAness' in sporadic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.026

10.1016/J.YGYNO.2005.08.026

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference